Kim Fox

2.1k total citations · 2 hit papers
8 papers, 1.5k citations indexed

About

Kim Fox is a scholar working on Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging and Surgery. According to data from OpenAlex, Kim Fox has authored 8 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cardiology and Cardiovascular Medicine, 2 papers in Radiology, Nuclear Medicine and Imaging and 1 paper in Surgery. Recurrent topics in Kim Fox's work include Heart rate and cardiovascular health (4 papers), Heart Rate Variability and Autonomic Control (4 papers) and Acute Myocardial Infarction Research (3 papers). Kim Fox is often cited by papers focused on Heart rate and cardiovascular health (4 papers), Heart Rate Variability and Autonomic Control (4 papers) and Acute Myocardial Infarction Research (3 papers). Kim Fox collaborates with scholars based in United Kingdom, United States and Netherlands. Kim Fox's co-authors include Patrice Jaillon, Guy Lerebours, Jeffrey Borer, Carolyn H. McCabe, Eugene Braunwald, Antoni Bayés de Luna, Alexander G. G. Turpie, Peter J. L. M. Bernink, Jean‐Marc Lablanche and Enrique Gurfinkel and has published in prestigious journals such as New England Journal of Medicine, Circulation and European Heart Journal.

In The Last Decade

Kim Fox

8 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Enoxaparin Prevents Death and Cardiac Ischemic Events in Unstable Angina/Non–Q-Wave Myocardial Infarction

1999 729 citations Elliott M. Antman, Carolyn H. McCabe et al. Circulation profile →
Ivabradine in Stable Coronary Artery Disease without Clinical Heart Failure

2014 320 citations Kim Fox, Ian Ford et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kim Fox United Kingdom	7	1.4k	375	353	345	40	8	1.5k
Libardo J. Meléndez Canada	6	797 0.6×	290 0.8×	188 0.5×	239 0.7×	19 0.5×	8	930
Rutger L. Anthonio Netherlands	17	1.6k 1.2×	1.1k 3.0×	284 0.8×	778 2.3×	82 2.0×	49	1.9k
Doralisa Morrone Italy	17	618 0.4×	415 1.1×	63 0.2×	290 0.8×	76 1.9×	50	992
Giulio Molon Italy	20	2.0k 1.4×	213 0.6×	87 0.2×	122 0.4×	57 1.4×	108	2.2k
W. Merx Germany	16	1.1k 0.8×	576 1.5×	82 0.2×	546 1.6×	65 1.6×	66	1.3k
E.M. Pelletier United States	3	794 0.6×	404 1.1×	314 0.9×	227 0.7×	36 0.9×	6	963
Sergio Dalla‐Volta Italy	12	622 0.4×	136 0.4×	236 0.7×	140 0.4×	47 1.2×	34	769
Pedro Morillas Spain	16	504 0.4×	301 0.8×	56 0.2×	91 0.3×	37 0.9×	66	768
D.S. Cannom United States	4	1.3k 0.9×	99 0.3×	216 0.6×	128 0.4×	52 1.3×	8	1.4k
Michael Hanna United States	20	2.0k 1.4×	119 0.3×	773 2.2×	160 0.5×	55 1.4×	44	2.2k

Countries citing papers authored by Kim Fox

Since Specialization

Citations

This map shows the geographic impact of Kim Fox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kim Fox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kim Fox more than expected).

Fields of papers citing papers by Kim Fox

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kim Fox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kim Fox. The network helps show where Kim Fox may publish in the future.

Co-authorship network of co-authors of Kim Fox

This figure shows the co-authorship network connecting the top 25 collaborators of Kim Fox. A scholar is included among the top collaborators of Kim Fox based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kim Fox. Kim Fox is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Chaitman, Bernard, Maria M. Brooks, Kim Fox, & Thomas F. Lüscher. (2018). ORBITA revisited: what it really means and what it does not?. European Heart Journal. 39(11). 963–965. 6 indexed citations

2.

Tendera, Michał, Olivier Chassany, Roberto Ferrari, et al.. (2015). Quality of Life With Ivabradine in Patients With Angina Pectoris. Circulation Cardiovascular Quality and Outcomes. 9(1). 31–38. 13 indexed citations

3.

Fox, Kim, Ian Ford, Philippe Gabríel Steg, et al.. (2014). Ivabradine in Stable Coronary Artery Disease without Clinical Heart Failure. New England Journal of Medicine. 371(12). 1091–1099. 320 indexed citations breakdown →

4.

Antoni, M. Louisa, Georgette E. Hoogslag, Helèn Boden, et al.. (2012). Cardiovascular Mortality and Heart Failure Risk Score for Patients After ST-Segment Elevation Acute Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention (Data from the Leiden MISSION! Infarct Registry). The American Journal of Cardiology. 109(2). 187–194. 28 indexed citations

5.

Asbury, Elizabeth, Carolyn Webb, Christine Wright, et al.. (2012). Cardiac Rehabilitation to Improve Physical Functioning in Refractory Angina: A Pilot Study. Cardiology. 122(3). 170–177. 33 indexed citations

6.

Fox, Kim. (2005). Future perspectives of If inhibition in various cardiac conditions. European Heart Journal Supplements. 7(suppl_H). H33–H36. 8 indexed citations

7.

Borer, Jeffrey, Kim Fox, Patrice Jaillon, & Guy Lerebours. (2003). Antianginal and Antiischemic Effects of Ivabradine, an I _f Inhibitor, in Stable Angina. Circulation. 107(6). 817–823. 349 indexed citations

8.

Antman, Elliott M., Carolyn H. McCabe, Enrique Gurfinkel, et al.. (1999). Enoxaparin Prevents Death and Cardiac Ischemic Events in Unstable Angina/Non–Q-Wave Myocardial Infarction. Circulation. 100(15). 1593–1601. 729 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact